We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$789M
AUM Growth
-$76.5M
Cap. Flow
+$29.9M
Cap. Flow %
3.79%
Top 10 Hldgs %
27.06%
Holding
1,208
New
169
Increased
297
Reduced
314
Closed
91

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.36M
2
TSN icon
Tyson Foods
TSN
+$4.6M
3
BAC icon
Bank of America
BAC
+$4.41M
4
HAS icon
Hasbro
HAS
+$3.88M
5
USB icon
US Bancorp
USB
+$3.09M

Sector Composition

Rank Sector Weight
1 Technology 13.04%
2 Healthcare 12.98%
3 Financials 11.5%
4 Consumer Staples 8.7%
5 Industrials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQLT icon
76
iShares MSCI Intl Quality Factor ETF
IQLT
$14.1B
$2.37M 0.3%
76,757
-12,017
-14% -$404K
VEA icon
77
Vanguard FTSE Developed Markets ETF
VEA
$234B
$2.37M 0.3%
58,006
+4,338
+8% +$193K
VRTX icon
78
Vertex Pharmaceuticals
VRTX
$123B
$2.35M 0.3%
8,349
+54
+0.7% +$14.5K
FXG icon
79
First Trust Consumer Staples AlphaDEX Fund
FXG
$228M
$2.27M 0.29%
36,929
+74
+0.2% +$4.73K
IEFA icon
80
iShares Core MSCI EAFE ETF
IEFA
$194B
$2.17M 0.28%
36,885
+5,249
+17% +$337K
EL icon
81
Estee Lauder
EL
$31.5B
$2.15M 0.27%
8,444
+184
+2% +$46.7K
TRNS icon
82
Transcat
TRNS
$877M
$2.08M 0.26%
36,616
VYMI icon
83
Vanguard International High Dividend Yield ETF
VYMI
$20.7B
$2.03M 0.26%
34,554
-3,000
-8% -$192K
BKNG icon
84
Booking.com
BKNG
$160B
$1.93M 0.25%
+27,650
New +$2.36M
DGRO icon
85
iShares Core Dividend Growth ETF
DGRO
$43.4B
$1.85M 0.23%
38,842
-362
-0.9% -$18.3K
LYV icon
86
Live Nation Entertainment
LYV
$42.8B
$1.72M 0.22%
20,872
+485
+2% +$46.7K
MMM icon
87
3M
MMM
$93.9B
$1.69M 0.21%
15,650
-68
-0.4% -$8.22K
OEF icon
88
iShares S&P 100 ETF
OEF
$20.4B
$1.65M 0.21%
9,567
FISV
89
Fiserv Inc
FISV
$28.9B
$1.62M 0.21%
18,227
+424
+2% +$41.1K
HDV
90
iShares Core High Dividend ETF
HDV
$14.8B
$1.59M 0.2%
79,235
+10,995
+16% +$232K
MCD icon
91
McDonald's
MCD
$195B
$1.5M 0.19%
6,073
+4,288
+240% +$1.06M
AMAT icon
92
Applied Materials
AMAT
$424B
$1.5M 0.19%
16,463
+8,078
+96% +$886K
ECL icon
93
Ecolab
ECL
$80.3B
$1.46M 0.19%
9,489
-487
-5% -$80.8K
GPN icon
94
Global Payments
GPN
$23.9B
$1.44M 0.18%
13,035
+489
+4% +$61.8K
MRK icon
95
Merck
MRK
$317B
$1.36M 0.17%
14,878
+13,231
+803% +$1.17M
AMGN icon
96
Amgen
AMGN
$220B
$1.3M 0.17%
5,363
+1,654
+45% +$405K
EXPE icon
97
Expedia Group
EXPE
$38.4B
$1.29M 0.16%
13,654
+373
+3% +$52.8K
PAYX icon
98
Paychex
PAYX
$42.1B
$1.26M 0.16%
11,028
+108
+1% +$13.6K
INTC icon
99
Intel
INTC
$510B
$1.24M 0.16%
33,121
+24,925
+304% +$1.08M
PBHC icon
100
Pathfinder Bancorp
PBHC
$102M
$1.19M 0.15%
59,681
+14,036
+31% +$278K

Similar funds

Howe & Rusling's Q2 2022 Portfolio in Review

As of Q2 2022, Howe & Rusling held 1,208 positions worth $789M, down 8.8% from $865M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Howe & Rusling deployed $29.9M of net new capital in Q2 2022, opening 169 new positions and adding to 297 existing holdings. Its largest new stake was AstraZeneca: 35,197 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $9.36M trimmed.

  • Howe & Rusling's largest Q2 2022 buy was AstraZeneca: 35,197 shares worth $4.65M.
  • Howe & Rusling added most to Lowe's Companies in Q2 2022, an estimated $6.75M increase.
  • Howe & Rusling's biggest Q2 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $9.36M.
  • Howe & Rusling fully exited Traeger in Q2 2022, selling an estimated $124K.
  • Howe & Rusling's ten largest holdings make up 27% of its $789M portfolio in Q2 2022.
  • Howe & Rusling opened 169 new positions and closed 91 in Q2 2022.
  • Howe & Rusling's portfolio value fell 8.8% quarter-over-quarter to $789M.

Based on Howe & Rusling's 13F filing for Q2 2022, filed 15 Aug 2022.